期刊文献+

同型半胱氨酸致动脉粥样硬化的机制研究 被引量:14

Induced Hyperhommocysteinemia in the Study of the Mechanisms of Otherosclerosis
下载PDF
导出
摘要 目的通过观察不同浓度同型半胱氨酸(Homocysteine,Hcy)干预对人脐静脉血管内皮细胞(HumanUmbilical Vein Endothelial Cells,HUVEC)和氧化应激的影响,探讨其在动脉粥样硬化(Atherosclerosis,AS)中的作用。方法体外培养HUVEC,将其分为正常对照组(Hcy 0μmol·L-1)、Hcy干预组(浓度分别为50、100、200、500μmol·L-1)、100μM Hcy+叶酸+VitB12治疗组,每个浓度组再分为24、48、72h三个时间组。MTT法检测各组细胞增殖抑制率,测定各浓度Hcy干预HUVEC 72h的氧化应激损伤指标。结果各浓度Hcy干预组随着Hcy浓度增高及干预时间延长HUVEC的细胞增殖抑制率增加,500μM Hcy 72h干预组最明显(P<0.05)。HUVEC内H2O2和MDA含量随Hcy浓度的增加而增加,Hcy100~500μM组与对照组比较差异均有统计学意义(P<0.01);Hcy100~500μM组HUVEC内SOD活性和T-AOC活性均较对照组降低(P<0.01),并且Hcy的浓度越高降低程度越明显。100μM Hcy+叶酸+VitB12治疗组与对照组比较上述各指标的差异均无统计学意义(P>0.05)。结论 Hcy抑制HUVEC增殖的作用呈剂量依赖关系,病理水平Hcy可以增强氧化应激损伤反应,而叶酸和VitB12对Hcy所致氧化应激损伤有一定的拮抗作用。 Objective To observe the effects of different concentrations of homocysteine (Homocysteine, Hey) intervention on human umbilical vein endothelial cells (Human umbilical vein endothelial cells, HU- VEC) and the effect of oxidative stress, and to explore its mechanisms in atherosclerosis (Atherosclerosis, AS) in rats. Methods HUVEC were cultured in vitro, which could be divided into the normal control group (Hey 0p, mol· L-l), Hey group(concentrations were 50, 100, 200, 500 pμmol · L-l), 100 μM Hey + VitB12 of folio acid treatment group. The concentration of each group was further divided into 24h, 48h, 72h group. Cell proliferation inhibition was detected by MTI. Results HUVEC cell proliferation inhibition rate increased, 500 μM Hcy 72h group was the most ( P 〈 0.05 ) while the concentration of Hcy group with the Hcy concentration increased and intervention time prolonged. HUVEC H202 and MDA content increased as the concentration of Hcy increased (P 〈0.01 ) ; HcylO0 - 500μM group HUVEC SOD activity and T - AOC activity were lower than those in control group ( P 〈 0.01 ). 100μM Hcy+ VitB12 of folic acid treatment group compared with the control group the differences of each index were not statistically significant (P 〉 0.05). Conclusion The Hcy inhibit HUVEC proliferation showed a dose dependent relationship. Pathologi- cal levels of Hcy could enhance oxidative stress response to injury. Folie acid and VitB12 has certain antago- nism against Hcy induced oxidative stress injury.
出处 《宁夏医科大学学报》 2012年第9期887-889,902,共4页 Journal of Ningxia Medical University
关键词 同型半胱氨酸 氧化应激损伤 动脉粥样硬化 homocysteine oxidative stress impair atherosclerosis
  • 相关文献

参考文献12

  • 1Zhou J, Austin RC. Contributions of hyperhomocys- teinemia to atherosclerosis: Causal relationship and po- tential mechanisms [ J ]. Biofactors, 2009, 35 ( 2 ) : 120 - 129.
  • 2Shastry S, Ingram A J, Scholey JW, et al. Homocys- teine induces mesangial cell apoptosis via activation of p38 - mitogen - activated protein kinase [ J ] . Kidney Int, 2007, 71(4) :304 -311.
  • 3Yan SK, Chang T, Wang H, et al. Effects of hydrogen sulfide on homocysteine - induced oxidative stress in vascp~lar smooth muscle cells [ J ]. Biochem Biophys Res Commun,20061351 (2) :485 - 491.
  • 4Schnyder G, Roffi M, Flammer Y, et al. Association of plasma homocysteine with restcnosis after percutaneous coronary angioplasty [ J ]. Eur Heart J,2002, 23 (9) : 726 - 733.
  • 5张敬各,王丽珍,韩晓群,姜怡邓,张瑞明,王树人.同型半胱氨酸对内皮细胞一氧化氮合酶系统的损伤机制及叶酸的拮抗效应[J].分子细胞生物学报,2007,40(1):17-23. 被引量:12
  • 6Cooke JP. The endothelium: a new target for therapy [J]. VASC MED, 2000, 5:49-53.
  • 7Ross R. The pathogenesis of atherosclerosisanupolate [J]. N Eng J Med, 1985,314:488 -493.
  • 8Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabo- lism [ J ]. J Clin Invest, 1976,57 (4) : 1079 - 1082.
  • 9Tsai JC, Perrella MA, Yoshizum iM. Promotion of vas- cular smooth muscle cell growth by homocysteine: a link to atherosclerosis [ J ]. Proc Natl Acad Sci USA, 1994, 91 (14) :6369 -6373.
  • 10Blundell G, Rose FA, Tudball N. Homocysteine in- duced endothelial cell toxicity and its protection [ J ]. Biochem Soc Trans, 1994,22 ( 3 ) : 341 S.

二级参考文献10

  • 1Chambers,J.C,O.A. Obeid,H. Refsum,P. Ueland,D.Hackett,J. Hooper,R.M. Turner,S.G. Thompson & J.S.Kooner,2000,Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet, 355(9203): 523-527.
  • 2Verhaar, M.C, E. Stroes & T.J. Rabelink,2002, Folate and cardiovascular disease. A rterioscler Thromb Vasc Biol,22:6-13.
  • 3Verhaar, M.C, R.M. Wever,J.J. Kastelein,T. van Dam, H.A. Koomans & T.J. Rabelink, 1998,5-methyltetrahydrofolate,the active from of folic acid,improves endothelial function in familial hypercholesterolemia. Circulation, 97(3) : 237-241.
  • 4Heydrick, S.J, 2004, L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells.Free Radic. Biol. Med,36(5):632-640.
  • 5Inoue,I,S. Goto,T. Matsunaga,T. Nakajima,T. Awata,S.Hokari,T. Komoda & S. Katayama,2001 ,The ligands/activators for peroxisome proliferator-activated receptor al pha (PPARalpha) and PPARgamma increase Cu^2+, Zn^2+-superoxide dismutase and decrease p22phox message expressions in essential endothelial cells. Metabolism: Clinical & Experimental, 50(1) : 3-11.
  • 6Stephens,N.G,A. Parsons,P.M. Scholfield,F. Kelly,K.Cheeseman & M.J. Mitchinson, 1996, Randomized controlled trial of vitamin E in patients with coronary disease:Cambridge Heart Antioxidant Study (CHAOS).Lancet, 347(9004) :781-786.
  • 7Hennekens,C.H,J.E. Buming,J.E. Manson,M. Stampfer,B. Rosner,N.R. Cook,C. Belanger,F. LaMotte,J.M. Gaziano,P.M. Ridker,W. Willett & R. Peto, 1996,Lack of effect of long-term supplementation with beta carotene on the incident of malignant neoplasms and cardiovascular disease.N. Engl.J. Med, 334(18):1145-1149.
  • 8Walldius, G, U. Erikson, A.G. Olsson, L. Bergstrand, K.Hadell, J. Johansson, L. Kaijser, C. Lassvik, J. Molgaard &S. Nilsson,et al, 1994,The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial(PQRST). Am. J. Cardiol,74(9) :875-883.
  • 9StUhlinger, M.C, R.K. Oka, E.E. Graf,I. Schmolzer, B.M.Upson,O. Kapoor,A. Szuba,M.R. Malinow,T.C. Wascher,O. Pachinger & J.P. Cooke , 2003 , Endothelial dysfunction induced by hyperhomocyst(e)inemia. Role of asymmetric dimethylarginine. Circulation, 108(8) : 933-938.
  • 10Lentz, S.R, R.N. Rodionov & S. Dayal, 2003, Hyperhomocysteinemia,endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atherosclerosis Supplemerits, 4: 61-65.

共引文献11

同被引文献129

引证文献14

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部